Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine M Fillmore

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Breast Cancer Research : BCR|March 28, 2008
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapyChristine M Fillmore, Charlotte Kuperwasser
Current Topics in Developmental Biology|January 21, 2014
Lung stem and progenitor cells in tissue homeostasis and diseaseKristen T Leeman, Christine M Fillmore, Carla F Kim
Seminars in Cancer Biology|May 3, 2012
The bed and the bugs: interactions between the tumor microenvironment and cancer stem cellsZafira Castaño, Christine M Fillmore, Carla F Kim, et al.
Nature Reviews. Cancer|July 25, 2014
Non-small-cell lung cancers: a heterogeneous set of diseasesZhao Chen, Christine M Fillmore, Peter S Hammerman, et al.
Cell|August 23, 2011
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cellsPiyush B Gupta, Christine M Fillmore, Guozhi Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signalingChristine M Fillmore, Piyush B Gupta, Jenny A Rudnick, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2005
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformationMichael S Isakoff, Courtney G Sansam, Pablo Tamayo, et al.
Nature|January 29, 2015
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.
Nature|September 26, 2018
Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.
The EMBO Journal|February 6, 2014
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasisAllison N Lau, Stephen J Curtis, Christine M Fillmore, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Breast Cancer Research : BCR|March 28, 2008
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapyChristine M Fillmore, Charlotte Kuperwasser
Current Topics in Developmental Biology|January 21, 2014
Lung stem and progenitor cells in tissue homeostasis and diseaseKristen T Leeman, Christine M Fillmore, Carla F Kim
Seminars in Cancer Biology|May 3, 2012
The bed and the bugs: interactions between the tumor microenvironment and cancer stem cellsZafira Castaño, Christine M Fillmore, Carla F Kim, et al.
Nature Reviews. Cancer|July 25, 2014
Non-small-cell lung cancers: a heterogeneous set of diseasesZhao Chen, Christine M Fillmore, Peter S Hammerman, et al.
Cell|August 23, 2011
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cellsPiyush B Gupta, Christine M Fillmore, Guozhi Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signalingChristine M Fillmore, Piyush B Gupta, Jenny A Rudnick, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2005
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformationMichael S Isakoff, Courtney G Sansam, Pablo Tamayo, et al.
Nature|January 29, 2015
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.
Nature|September 26, 2018
Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.
The EMBO Journal|February 6, 2014
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasisAllison N Lau, Stephen J Curtis, Christine M Fillmore, et al.
Pageof 2